0
Signin
countryflagUK

8082-737-676

0R15 8539.0 2.1534% 0R1E 8600.0 3.3654% 0M69 None None% 0R2V 190.25 -0.1312% 0QYR 1345.5 2.0871% 0QYP 424.0 0.5931% 0LCV 146.6464 -1.3147% 0RUK None None% 0RYA 1631.0 -0.6094% 0RIH 171.3 0.9131% 0RIH 174.9 2.1016% 0R1O 186.0 9820.0% 0R1O None None% 0QFP None None% 0M2Z 298.3 -0.6495% 0VSO None None% 0R1I None None% 0QZI 474.5 0.6363% 0QZ0 220.0 0.0% 0NZF None None%

Blue-Chip

Are you an investor that on the lookout for financially sound for companies that have operated for many years and have dependable earnings, often paying dividends to investors? You are the right place

|
Update on NYSE -Listed Pharmaceuticals Stock– Bristol Myers Squibb Company
Team Kalkine

Update on NYSE -Listed Pharmaceuticals Stock– Bristol Myers Squibb Company

  • May 06, 2024
  •   | Read Time : 5 min
Technical Analysis on One NYSE- Listed Healthcare Stock- NVO
Team Kalkine

Technical Analysis on One NYSE- Listed Healthcare Stock- NVO

  • May 03, 2024
  •   | Read Time : 5 min
How is Needle Moving in This OTC-Listed EV ADR– BYD Company Limited
Team Kalkine

How is Needle Moving in This OTC-Listed EV ADR– BYD Company Limited

  • May 03, 2024
  •   | Read Time : 5 min
One NASDAQ – Listed Defence Stock at Resistance Level: Arm Holdings plc
Team Kalkine

One NASDAQ – Listed Defence Stock at Resistance Level: Arm Holdings plc

  • Apr 30, 2024
  •   | Read Time : 5 min
An Update on NASDAQ-Listed Technology Stock– Meta Platforms Inc
Team Kalkine

An Update on NASDAQ-Listed Technology Stock– Meta Platforms Inc

  • Apr 29, 2024
  •   | Read Time : 5 min
An Update on One Global Mining Company – AAL
Team Kalkine

An Update on One Global Mining Company – AAL

  • Apr 25, 2024
  •   | Read Time : 10 Mins
An Update on One Biopharmaceutical Company – AZN
Team Kalkine

An Update on One Biopharmaceutical Company – AZN

  • Apr 23, 2024
  •   | Read Time : 10 Mins
Technical Analysis on One NASDAQ- Listed Technology Stock- SMCI
Team Kalkine

Technical Analysis on One NASDAQ- Listed Technology Stock- SMCI

  • Apr 22, 2024
  •   | Read Time : 5 min

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions